Evidence map›Paper›PMID 42584331›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Hybrid Magneto-Plasmonic Nanostructures for Enhanced Dual-Mode Hyperthermia.

Amirhossein Sanchooli, Patricia de la Presa

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amirhossein SanchooliDepartment of Physics, Faculty of Science, University of Kurdistan, Sanandaj 66177-15175, Iran.ORCID 0000-0001-9472-9879
Patricia de la PresaInstitute of Applied Magnetism, Complutense University of Madrid, A6 22.500 km, 28230 Las Rozas, Spain.ORCID 0000-0002-9456-8320

Funding

Ministerio de Ciencia, Innovación y Universidades PID2024-156318OB-I00
6 · The paper itself

Abstract

This study addresses a major challenge in hyperthermia therapy: achieving fast and efficient heat generation in target tissues. A novel magneto-plasmonic nanostructure is developed by combining gold nanorods (GNRs) and iron oxide nanoparticles (IONPs), each synthesized independently to compare their individual and combined heating performance. A key innovation was the use of (3-mercaptopropyl)trimethoxysilane (MPTMS) as a covalent linker, enabling the stable integration of both components into a single hybrid system. Under simultaneous near-infrared (NIR) laser and alternating magnetic field exposure, the hybrid nanostructure exhibited a rapid and intense temperature rise, surpassing the effects of either material alone. A control sample consisting of a physical mixture of the two components (GNR + IONP) reached SAR values comparable to those of the covalently linked hybrid (GNR + MPTMS + IONP) under simultaneous excitation, the two being equal within experimental error. Although the chemical linkage modifies the optical absorbance of the GNRs and may partially restrict the Brownian relaxation of the magnetic nanoparticles, these effects do not translate into a measurable loss of heating efficiency under combined activation. Importantly, the covalent linkage yields a robust, structurally stable assembly whose components move together-an essential requirement for functionalities such as magnetic guidance and targeted delivery of the whole nanostructure, which a simple physical mixture cannot provide. As a physicochemical proof of concept, these results establish the dual-mode heating performance of the hybrid nanostructure in aqueous suspension and motivate the biological evaluation required for any future therapeutic use.

Indexed as

dual-mode hyperthermiagold nanorodsmagnetic nanoparticlesmagneto-plasmonic hybrid nanostructuresphotothermal and magnetic heating

Identifiers

PMID42584331
PMCPMC13468272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.